Several biomarkers for AKI like tissue inhibitor of metalloproteinase-2, insulin-like growth factor binding protein-7, and neutrophil gelatinase-associated lipocalin have the potential to substantially improve the diagnostic approach to AKI in the future [26, 27]. Here, IGFBP7 is linked to acute kidney injury.